BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 35162079)

  • 21. Do financial performance and firm's value affect the quality of corporate social responsibility disclosure: Moderating role of chief executive officer's power in China.
    Na C; Tian G; Rauf F; Naveed K
    Front Psychol; 2022; 13():925323. PubMed ID: 36059787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Will Green CSR Enhance Innovation? A Perspective of Public Visibility and Firm Transparency.
    Wu W; Liu Y; Chin T; Zhu W
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29401714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corporate social responsibility initiatives and their role in firms' reputation and green economic recovery through organizational trust.
    Zheng SY; Chen R; Liu H; Li J; Fahad S; Li B
    Environ Sci Pollut Res Int; 2023 Sep; 30(45):101817-101828. PubMed ID: 37659017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does institutional quality complement the relationship between ownership structure and corporate social responsibility?
    Ali S; Zhang R; Talha M; Ali Z
    Heliyon; 2024 Jun; 10(11):e31994. PubMed ID: 38882305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How High-Polluting Firms Suffer from Being Distracted form Intended Purpose: A Corporate Social Responsibility Perspective.
    Zhao XZ; Chen J; Chen FW; Wang W; Xia S
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33317027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do Embedded and Peripheral Corporate Social Responsibility Activities Lower Employees' Turnover Intentions?
    Liu Y; Ijlal K; Hanif MS; Khurshid A; Ahmed Z
    Front Psychol; 2022; 13():926962. PubMed ID: 35814161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does CSR performance improve corporate immunity to the COVID-19 pandemic? Evidence from China's stock market.
    Tian J; Wang X; Wei Y
    Front Public Health; 2022; 10():956521. PubMed ID: 36052006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the Effect of Board Gender Diversity on CSR Reporting Through Moderating Role of Political Connections in Chinese Listed Firms.
    Shaheen R; Yang H; Bhutto MY; Bala H; Khan FN
    Front Psychol; 2021; 12():796470. PubMed ID: 35035372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improve employee-organization relationships and workplace performance through CSR: Evidence from China.
    Zhang Y; Dong C
    Front Psychol; 2022; 13():994970. PubMed ID: 36405139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moderating Effect of Chief Executive Officer Narcissism in the Relationship Between Corporate Social Responsibility and Green Technology Innovation.
    Yang H; Shi X; Wang S
    Front Psychol; 2021; 12():717491. PubMed ID: 34744876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corporate social responsibility and internal stakeholders' health and well-being in Europe: a systematic descriptive review.
    Macassa G; McGrath C; Tomaselli G; Buttigieg SC
    Health Promot Int; 2021 Aug; 36(3):866-883. PubMed ID: 32856071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Returnee Executives, Corporate Social Responsibility, and Stock Price Synchronicity.
    Gao D; Zhao Y; Tian Q
    Front Psychol; 2022; 13():950436. PubMed ID: 35911051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corporate Social Responsibility and Cheating Behavior: The Mediating Effects of Organizational Identification and Perceived Supervisor Moral Decoupling.
    Luan K; Lv M; Zheng H
    Front Psychol; 2021; 12():768293. PubMed ID: 35058841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inter-Firm Executive Mobility and Corporate Social Responsibility: Evidence From China.
    Wang J; Cao J
    Front Psychol; 2022; 13():904450. PubMed ID: 35719529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corporate immunity to the COVID-19 pandemic.
    Ding W; Levine R; Lin C; Xie W
    J financ econ; 2021 Aug; 141(2):802-830. PubMed ID: 34580557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diversity of returnee executives' foreign experience and corporate social responsibility performance.
    Wu Y; Zhang W; Li H
    PLoS One; 2024; 19(4):e0300262. PubMed ID: 38557680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Making Sense of Corporate Social Responsibility and Work.
    Seivwright AN; Unsworth KL
    Front Psychol; 2016; 7():443. PubMed ID: 27047439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The philanthropic response of substantive and symbolic corporate social responsibility strategies to COVID-19 crisis: Evidence from China.
    Zhong M; Zhao W; Shahab Y
    Corp Soc Responsib Environ Manag; 2022 Mar; 29(2):339-355. PubMed ID: 35465450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impacts of organizational green culture and corporate social responsibility on employees' responsible behaviour towards the society.
    Abbas J; Dogan E
    Environ Sci Pollut Res Int; 2022 Aug; 29(40):60024-60034. PubMed ID: 35414156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of Narcissistic CEOs on Corporate Social Responsibility (CSR) Choices: The Moderating Role of the Legal Environment.
    Gao Q; Gao L; Long D; Wang Y
    Psychol Res Behav Manag; 2023; 16():3199-3217. PubMed ID: 37588249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.